GSK plc Form 6-K Summary
Business context and reporting period
GSK plc filed this Form 6-K on 6 October 2026, reporting an admission of ordinary shares to trading on the London Stock Exchange Main Market. The notice covers 7 August through 2 October 2026 and relates to the GlaxoSmithKline plc Share Save Plan 2022.
Share admission and financial metrics
- 19,352 ordinary shares of 31¼ pence each were admitted to trading.
- Total ordinary shares admitted to trading following the admission: 4,316,311,662.
- The shares are fully fungible with existing ordinary shares; ISIN GB00BN7SWP63.
- The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics.
Changes, outlook, and risks
This is an administrative share-admission notice, not a financial results or outlook announcement. It contains no guidance, management commentary, or discussion of risks or contingencies. The filing does not state the proceeds, if any, associated with the admission.
Important facts to verify
- Confirm the 19,352-share admission and the stated total of 4,316,311,662 shares against the London Stock Exchange notice.
- Confirm the admission is under the existing block listing for the Share Save Plan 2022.
- Check subsequent filings for any additional share admissions or financial information.